Skip to main content
. Author manuscript; available in PMC: 2020 Nov 12.
Published in final edited form as: J Am Coll Cardiol. 2019 Nov 12;74(19):2333–2345. doi: 10.1016/j.jacc.2019.08.1057

Figure 2. Relationship of biomarkers to increasing amounts of late gadolinium enhancement (LGE).

Figure 2.

N-terminal pro-brain natriuretic peptide (NTproBNP) and high sensitivity troponin T (cTnT) were measured in each patient as was the extent of LGE as a % of left ventricular mass on cardiac magnetic resonance imaging. Left – Median NTproBNP showing increasing levels relative to patients with increasing amounts of LGE (P<0.001 for trend). Right – similar trend shown for cTnT (separated by gender due to different normal values) with p<0.001 for trend for both.